The ACS recognizes the follow- ing facts:
•The preponderance of medical research in the last 30 years
has shown a positive association
between the concurrent use of opioids and motor vehicle crashes.
•Driving under the influence of
controlled substances, including
opioids, leads to impaired driving.
The ACS supports efforts to
promote, enact, and sustain legislation and policies that encourage
•Educating patients on the dangers
of driving or engaging in other
hazardous activities while taking
•Educating patients using opioids about the potential risks of
using concurrent psychoactive
•Requiring prescribers to be certain
their patients receive instructions
about what constitutes safe use of
opioids, sedatives, and other psychoactive medications ♦
Statement on Opioids and
Motor Vehicle Crash Prevention
The following statement was developed by the American College of Surgeons (ACS) Committee on
Trauma’s (COT) Injury Prevention and Control Committee to educate surgeons and other health care
professionals on the risk of motor vehicle crashes due to driving under the influence of opioids and
evidence-based prevention activities intended to alleviate opioid-related motor vehicle injuries.
The ACS Board of Regents approved the statement at its June 2017 meeting in Chicago, IL.
Asbridge M, Cartwright J, Langille D. Driving under the influence of opioids among
high school students in Atlantic Canada: Prevalence, correlates, and the role of
medical versus recreational consumption. Accid Anal Prev. 2015;75:184-191.
Center for Substance Abuse Research. University of Maryland. One-third of fatally
injured drivers with known test results tested positive for at least one drug in 2009.
Cesar Fax. 2010; 19( 4). Available at: www.cesar.umd.edu/cesar/cesarfax/vol19/19-49.
pdf. Accessed August 30, 2017.
Disney L, Pelkey S, Wipperman M, et al. Drug testing and drug-involved driving of
fatally injured drivers in the United States: 2005–2009. Office of National Drug
Control Policy, Executive Office of the President. October 2011.Available at: https://
report_october_2011.pdf. Accessed August 25, 2017.
DuPont, RL, Logan, BK, Shea CL, et al. Drugged driving research: A white paper.
Institute for Behavior and Health, Inc. March 31, 2011. Available at: https://
obamawhitehouse.archives.gov/sites/default/files/ondcp/issues-content/drugged-driving/nida_dd_paper.pdf. Accessed August 25, 2017.
Gjerde H, Strand MC, Mørland J. Driving under the influence of non-alcohol drugs–an
update, part I: Epidemiological studies. Forensic Sci Rev. 2015; 27( 2):89-113.
Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid
dose and risk of road trauma in Canada: A population-based study. JAMA Intern
Med. 2013;173( 3):196-201.
Hetland A, Carr DB. Medications and impaired driving: A review of the literature. Ann
Pharmacother. 2014; 48( 4):494-506.
Monarrez-Espino J, Laflamme L, Rausch C, Elling B, Möller J. New opioid analgesic
use and the risk of injurious single-vehicle crashes in drivers aged 50–80 years: A
population-based matched case-control study. Age and Ageing. 2016; 45( 5):628-634.
National Institute on Drug Abuse. Drugged driving. Drug facts. Revised June 2016.
Available at: www.drugabuse.gov/publications/drugfacts/drugged-driving.
Accessed August 25, 2017.
Teater D. The psychological and physical side effects of pain medications. National Safety
Council. February 15, 2015. Available at: www.nsc.org/RxDrugOverdoseDocumen
ts/900006497-ADV-Rx-Side-Effects-WhitePaper.pdf. Accessed August 25, 2017.
U.S. Department of Transportation. National Highway Traffic Safety Administration.
Traffic Safety Facts. Drug involvement of fatally injured drivers. November 2010.
Available at: https://crashstats.nhtsa.dot.gov/Api/Public/ViewPublication/811415.
Accessed August 25, 2017.
Walsh JM, Flegel R, Atkins R, et al. Drug and alcohol use among drivers admitted to a
level- 1 trauma center. Accid Anal Prev. 2005; 37( 5):894-901.
Wilson F A, Stimpson, J P, Pagán J A. Fatal crashes from drivers testing positive for
drugs in the U.S., 1993–2010. Public Health Rep. 2014;129( 4):342-350.